Page 70 - புனே அடிப்படையிலானது சீரம் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Coronavirus | Centre contradicts SII on vaccine pricing, to purchase at ₹150 per dose Updated: Updated: April 25, 2021 00:09 IST There appears to be a change in the Covishield vaccine maker’s position with regard to its pricing Share Article AAA Adar Poonawalla, Chief Executive Officer (CEO) of the Serum Institute of India. File   | Photo Credit: Reuters There appears to be a change in the Covishield vaccine maker’s position with regard to its pricing On April 24, Adar Poonawalla, CEO of Serum Institute, issued a statement to address the “ongoing public scepticism and confusion towards the pricing of Covishield”. The statement tried to address the controversy over whether the price of the vaccine at ₹600 (nearly $8) per dose for private hospitals was more than its cost when it was exported. But it did not refer to the issue of whether the vaccine would be priced differently for procurement by the Centre and the State governments.

South africaHarsh vardhanNarendra modiAdar poonawallaPascal soriotUnion healthSerum institute of indiaHealth ministryPune based serum instituteUnion health ministerHealth ministerIndia todayPrime minister narendra modiகடுமையான வர்தன்நரேந்திர மோடிஅடார் பூனாவல்ல